Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M MEAD

Showing results (191-200 of 226) with videos related to

Pageof 23
Sort By:
The Journal of Urology|September 29, 1998
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk groupS J Harland, P A Cook, S D Fossa, et al.
Cell Biophysics|January 1, 1994
Mechanisms in removal of tumor by antibodyG T Stevenson, A J Bell, T R Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)R Timothy D Oliver, Graham M Mead, Gordon J S Rustin, et al.
Cancer|March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumorsS D Fosså, C Bokemeyer, A Gerl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.
Journal of the National Cancer Institute|January 8, 2011
Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-upGraham M Mead, Sophie D Fossa, R Timothy D Oliver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's diseaseP D Simmonds, G M Mead, J W Sweetenham, et al.
Blood|July 10, 2008
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)Graham M Mead, Sharon L Barrans, Wendi Qian, et al.
British Journal of Cancer|October 29, 1998
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working PartyG M Mead, M Russell, P Clark, et al.
Plos Pathogens|September 3, 2024
Norovirus-mediated translation repression promotes macrophage cell deathTurgut E Aktepe, Joshua M Deerain, Jennifer L Hyde, et al.
Pageof 23

Showing results (191-200 of 226) with videos related to

Sort By:
Pageof 23
The Journal of Urology|September 29, 1998
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk groupS J Harland, P A Cook, S D Fossa, et al.
Cell Biophysics|January 1, 1994
Mechanisms in removal of tumor by antibodyG T Stevenson, A J Bell, T R Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)R Timothy D Oliver, Graham M Mead, Gordon J S Rustin, et al.
Cancer|March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumorsS D Fosså, C Bokemeyer, A Gerl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.
Journal of the National Cancer Institute|January 8, 2011
Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-upGraham M Mead, Sophie D Fossa, R Timothy D Oliver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's diseaseP D Simmonds, G M Mead, J W Sweetenham, et al.
Blood|July 10, 2008
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)Graham M Mead, Sharon L Barrans, Wendi Qian, et al.
British Journal of Cancer|October 29, 1998
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working PartyG M Mead, M Russell, P Clark, et al.
Plos Pathogens|September 3, 2024
Norovirus-mediated translation repression promotes macrophage cell deathTurgut E Aktepe, Joshua M Deerain, Jennifer L Hyde, et al.
Pageof 23